Allscripts considers buyout offers
Blackstone, Carlyle and Silver Lake are among the bidders for this electronic health records company.
The electronic health-records provider, which has retained Citigroup (C) as its advisor on the sale, now wants second-round offers in the next three to four weeks, sources told Bloomberg.
Allscripts has had a troubled year. After the company fired chairman Phil Pead in April, three directors also left with Pead in protest. Allscripts then faced a proxy battle with major shareholder, hedge fund Healthcor Management, which eventually placed three of its candidates on Allscript’s board in June.
Leo Carpio, an analyst at Caris & Co in New York, noted on October 1 that Allscripts may have felt greater pressure to sell after it lost out on a $302 million contract to manage the record systems for New York City public hospitals.
In the past week, a slew of analysts covering Allscripts have revised their targets on shares of the company. ISI Group moved Allscripts to Overweight from Buy and upped its price target to $14.50 from $11.50. Analysts at Cowen moved the company to Outperform from Neutral, while those at Robert W. Baird raised their target from $15 to $17.
Sterne Agee, which has a Buy rating on Allscripts, also lifted its price target to $15 from $13.50, saying in a note, "Our analysis suggests a $15-$19 valuation range for MDRX shares should a go-private transaction be consummated by year-end. At the low end, this valuation range is 20% above today’s closing price, while the top end implies 50% upside. As such, we have raised our price target to $15 per share from $13.50."
Shares of Allscripts were down 29.62% year to date before Monday’s open.
More from Minyanville
MORE ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The retailer labels the character's fake memoir as non-fiction. This comes weeks after it categorized the the Bible as fiction.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.